“Adaptive Licensing and Conditional Approval: A Perspective on Evidence Owed After Market Entry”. Translational Medicine & Therapeutics Journal 2, no. 2 (November 11, 2023): 92–100. Accessed November 5, 2026. https://inkwise.org/index.php/TMTJ/article/view/87.